Brief: Bluejay Diagnostics Reports Q1 Loss Per Share $0.10
20/04/2022 21:55
April 20 (Reuters) - Bluejay Diagnostics Inc BJDX.O :
* BLUEJAY DIAGNOSTICS, INC. REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS
* Q1 LOSS PER SHARE $0.10
* BLUEJAY DIAGNOSTICS - CASH POSITION SUFFICIENT TO FUND
OPERATIONS BEYOND DATE OF ANTICIPATED REGULATORY APPROVAL,
SYMPHONY IL-6 TEST COMMERCIALIZATION
Source text for Eikon: ID:nGNX5LS8mj
Further company coverage: BJDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bluejay Diagnostics
See all newsBrief: Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study
Brief: Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership
Bluejay Diagnostics Q1 net loss unchanged
Brief: Bluejay Diagnostics, Inc. Announces Completion Of 624 Patient Enrollments In Symon-Ii Pivotal Clinical Trial
Brief: Bluejay Diagnostics Provides Corporate Update And 2026 Strategic Outlook